Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus.
Mol Cancer Ther. 2021 Oct;20(10):1836-1845. doi: 10.1158/1535-7163.MCT-20-1105. Epub 2021 Jul 12.
Mol Cancer Ther. 2021.
PMID: 34253597
Free PMC article.
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.
Mpilla GB, Philip PA, El-Rayes B, Azmi AS.
Mpilla GB, et al.
World J Gastroenterol. 2020 Jul 28;26(28):4036-4054. doi: 10.3748/wjg.v26.i28.4036.
World J Gastroenterol. 2020.
PMID: 32821069
Free PMC article.
Review.
Item in Clipboard
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth.
Khan HY, Mpilla GB, Sexton R, Viswanadha S, Penmetsa KV, Aboukameel A, Diab M, Kamgar M, Al-Hallak MN, Szlaczky M, Tesfaye A, Kim S, Philip PA, Mohammad RM, Azmi AS.
Khan HY, et al. Among authors: mpilla gb.
Cancers (Basel). 2020 Mar 22;12(3):750. doi: 10.3390/cancers12030750.
Cancers (Basel). 2020.
PMID: 32235707
Free PMC article.
Item in Clipboard
Cite
Cite